On ECHEMI
Home > Drugs > Bladder cancer
Bladder cancer
Bladder cancer is the most common malignant tumor of the urinary system, and its incidence rate ranks first among malignant tumors of the urinary system. The cause of the disease is still unclear, but it is generally believed to be related to frequent contact with carcinogens such as naphthylamine and benzidine. Dyes, rubber, plastic products, paints, detergents, etc. commonly seen in daily life also have potential carcinogenic risks. Smoking is not only harmful to the respiratory system, but also causes bladder cancer. In addition, certain diseases such as leukoplakia, glandular cystitis, urethral stones, and urine retention may also induce bladder cancer. The incidence rate of bladder cancer in men and women is about 5:2, and there are about 54,500 new cases in the United States each year (estimated in 1997).
  • Site of disease:

    bladder
  • Infectious :

    Not contagious
  • Frequent population:

    Age 51-70
  • Related symptoms:

    Detrusor areflexia pubic mass painless hematuria pururia urination disorder
  • Concurrent disease:

Related Drugs
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:

Hainan Weikang Pharmaceutical(Qianshan) Co., Ltd.

Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:

Harbin Medical University Pharmaceutical Co., Ltd.

Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:

Harbin Medical University Pharmaceutical Co., Ltd.

Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:

Harbin Medisan Pharmaceutical Co., Ltd.

Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:

Heilongjiang Dilong Pharmaceutical Co., Ltd.

Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:

Harbin Shengtai Biopharmaceutical Co., Ltd.

Teniposide Injection
Indication: This product is suitable for the treatment of the following diseases, usually in combination with other anticancer drugs: malignant lymphoma; Hodgkin's disease; acute lymphocytic leukemia, high-risk cases in adults and children; intracranial malignancies: glioblastoma, vascular dysplasia, astrocytoma; bladder cancer; neuroblastoma and other solid tumors in children.
Recombinant human interleukin-2 for injection
Indication: 1. It is used for the treatment of malignant tumors such as renal cell carcinoma, melanoma, breast cancer, bladder cancer, liver cancer, rectal cancer, lymphoma, lung cancer, etc. It is used for the control of cancerous pleural effusion and ascites, and can also be used for the cultivation of lymphokine-activated killer cells. 2. It is used for the treatment of tumor patients after surgery, radiotherapy and chemotherapy to enhance the body's immune function. 3. It is used for the treatment of congenital or acquired immunodeficiency to improve the patient's cellular immune function and anti-infection ability. 4. The treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, etc. 5. It has a certain therapeutic effect on certain viral and bacillary diseases, and intracellular parasitic infectious diseases, such as hepatitis B, leprosy, tuberculosis, and Candida albicans infection.
Manufacturer:

Changchun Lnstitute of Biological Products Co., Ltd.

Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:

Nanjing Chia Tai-tianqing Pharmaceutical Co., Ltd.

Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:

Zhejiang Hisun Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.